top of page
News
Chat
Insights
Portfolios
Education
About
Plans/Pricing
API/MCP
Gene Editing for Investors
Summary The first in vivo clinical trial results using in vivo CRISPR gene editing technology were reported yesterday (6/26/21) by...
Jun 27, 2021
Jump start your biotech due diligence
Get started →
Our platform helps you uncover your next biotech investment opportunity
bottom of page
